Skip to content

Clinical trials

Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Country / region: United States Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20018
20023
20035
20044
20053
20067
20077
20086
20093
20109
20112
20121
20135
20141
20157
20165
20178
20186
20199
20206
20219
20225
20238
20248
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Terminated32
Recruiting22
Active, not recruiting13
Withdrawn7
Unknown status6
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)30
Memorial Sloan Kettering Cancer Center15
M.D. Anderson Cancer Center9
Alliance for Clinical Trials in Oncology6
University of Chicago5
Abramson Cancer Center at Penn Medicine4
Dana-Farber Cancer Institute3
Roswell Park Cancer Institute3
University of Pennsylvania3
Verastem, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant162
Carcinoma, Non-Small-Cell Lung36
Mesothelioma31
Lung Neoplasms20
Solitary Fibrous Tumor, Pleural18
Esophageal Neoplasms14
Neoplasms14
Ovarian Neoplasms14
Pancreatic Neoplasms14
Uterine Cervical Neoplasms14

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.